Evolution of FXI(a) as a target for antithrombotic therapy
Event:
ESC Congress 2023
Congress Presentation
About the speaker
Doctor Jeffrey Weitz
Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
31
presentations
1
follower
5 more presentations in this session
Epidemiology of stroke and disease burden
Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)
Uncovering the unmet need for patients:
- with atrial fibrillation at risk of stroke
- acute non-cardioembolic ischemic stroke or high-risk TIA
Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE) Professor M. Sharma (Hamilton, CA)
Outlining the clinical evidence landscape for FXI(a) inhibition:
- stroke and bleeding prevention for patients with AF at risk of stroke
- secondary stroke prevention in acute non-cardioembolic ischemic stroke or high-risk TIA
Speaker: Professor J. De Groot (Amsterdam, NL) Professor M. Sharma (Hamilton, CA)
Access the full session
About the event
